Cover Image

Indacaterol: A novel, Inhaled Beta-2 agonist for COPD

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Ved Prakash (Author), Arpita Singh (Author), Anubhuti Singh (Author), Surya Kant (Author), Ajay Kr Verma (Author), Ankit Bhatia (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2015-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Indacaterol: A novel, Inhaled Beta-2 agonist for COPD
by: Ved Prakash, et al.
Published: (2015)

Tubercular round pneumonia simulating a mass lesion in an adult
by: Ved Prakash, et al.
Published: (2018)

ORALAIR: A novel sublingual immunotherapy
by: Arpita Singh, et al.
Published: (2016)

The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In Vitro
by: Ronald Anderson, et al.
Published: (2014)

Oral tuberculosis mimicking malignancy
by: Ajay Kumar Verma, et al.
Published: (2015)

Oral tuberculosis mimicking malignancy
by: Ajay Kumar Verma, et al.
Published: (2015)

Crizotinib in treatment of lung cancer
by: Arpita Singh, et al.
Published: (2017)

Crizotinib in treatment of lung cancer
by: Arpita Singh, et al.
Published: (2017)

Pulmonary artery pseudoaneurysm: An uncommon fatal complication associated with tubercular empyema
by: Ved Prakash, et al.
Published: (2015)

Mirabegron: A first-in-class beta-3 agonist for overactive bladder
by: Suruchi Aditya, et al.
Published: (2015)

A rare cause of pneumothorax: Diesel aspiration pneumonitis
by: Ajay K Verma, et al.
Published: (2018)

A rare cause of pneumothorax: Diesel aspiration pneumonitis
by: Ajay K Verma, et al.
Published: (2018)

Cost-Effectiveness of Once-Daily, Single-Inhaler Indacaterol Acetate/ Glycopyrronium Bromide/ Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma in Canada
by: Mtibaa M, et al.
Published: (2021)

Tuberculosis of the thyroid gland
by: Ajay Kumar Verma, et al.
Published: (2017)

Tuberculosis of the thyroid gland
by: Ajay Kumar Verma, et al.
Published: (2017)

Single Inhaler LABA/LAMA for COPD
by: Mario Malerba, et al.
Published: (2019)

Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA)
by: Bjermer L, et al.
Published: (2015)

Choosing the right inhaler for your asthma or COPD patient
by: Usmani OS
Published: (2019)

Beta-Adrenergic Agonists
by: Giovanni Barisione, et al.
Published: (2010)

Pulmonary actinomycosis masquerading as a malignant lung tumor
by: Ved Prakash, et al.
Published: (2015)

Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β2-agonists in patients with atopic asthma
by: Bateman ED, et al.
Published: (2018)

Key points in effective inhaler technique training for asthma and COPD patients
by: Hiroyuki Ohbayashi
Published: (2020)

Impact of inhalation therapy on the incidence of carious lesions in patients with asthma and COPD
by: Branislava Velicki Bozejac, et al.

Eosinophil Inflammation and Hyperresponsiveness in the Airways as Phenotypes of COPD, and Usefulness of Inhaled Glucocorticosteroids
by: Hiroaki Kume, et al.
Published: (2019)

Asthma and COPD Patients' Perception of Appropriate Metered-Dose Inhaler Technique
by: Wijdan H. Ramadan, et al.
Published: (2020)

LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use
by: Varvara Boryushkina, et al.
Published: (2020)

Characteristics of the COPD Patients for the Implementation of the Smartphone Application for the COPD: An Implementation Study
by: Ashwani Verma, et al.
Published: (2024)

Inhaled Short-Acting Beta Agonist Treatment-Associated Supraventricular Tachycardia in Children: Still a Matter of Concern in Pediatric Emergency Departments?
by: Bertrand Tchana, et al.
Published: (2023)

Laboratory approach for diagnosis of toluene-based inhalant abuse in a clinical setting
by: Raka Jain, et al.
Published: (2016)

Rational use of inhaled corticosteroids for the treatment of COPD: a plain language summary
by: Amnon Ariel, et al.
Published: (2023)

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD
by: Paolo Montuschi, et al.
Published: (2018)

The importance of reminders and patient preferences to improve inhaler technique in older adults with COPD
by: P. Barnestein-Fonseca, et al.
Published: (2023)

The Effects of Inhaled β-Adrenergic Agonists in Transient Tachypnea of the Newborn
by: Esengul Keleş MD, et al.
Published: (2016)

Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD
by: Shih-Yu Chen, et al.
Published: (2021)

Inhaler Technique and Self-reported Adherence to Medications Among Hospitalised People with Asthma and COPD
by: Astrid Elander, et al.
Published: (2020)

Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
by: Emanuela Resta, et al.
Published: (2022)

Comparison of efficacy between long-acting beta 2-agonists (formoterol fumarate) and leukotriene-receptor antagonists (montelukast) as add-on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma
by: Sasikala Kumaravel, et al.
Published: (2014)

In-silico primer designing and PCR for detection of novel coronavirus-19
by: Shashi Kant Tiwari, et al.
Published: (2020)

Prognostic value of oxygen inhalation therapy for simple nocturnal hypoxemia in COPD: a meta-analysis
by: Ling Sun, et al.
Published: (2023)

Development and Evaluation of Isoniazid Loaded Silk Fibroin Microsphere
by: Narinder Singh, et al.